Holen Sie sich die Stockscreener-App
29.54
4.20%
-1.295
Schlusskurs vom Vortag:
$30.84
Offen:
$30.75
24-Stunden-Volumen:
316.33K
Relative Volume:
1.16
Marktkapitalisierung:
$544.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-16.95%
1M Leistung:
-28.61%
6M Leistung:
+81.78%
1J Leistung:
+0.00%
1-Tages-Spanne:
$29.32
$31.12
1-Wochen-Bereich:
$29.32
$35.44
52-Wochen-Spanne:
$15.00
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Vergleichen Sie TECX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
29.54 | 544.78M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Tectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
11 Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
Tectonic Therapeutic to Participate in March Investor Conferences - The Manila Times
Exclusive Access: Tectonic's Management Team Opens Door to Investors at Major March Conferences - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Analyzing Fresh Tracks Therapeutics (NASDAQ:FRTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Timothy A. Springer Buys 129,294 Shares - MarketBeat
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 3.2%Should You Sell? - MarketBeat
Daniel Lochner Acquires 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Contrasting Tectonic Therapeutic (NASDAQ:TECX) and Vir Biotechnology (NASDAQ:VIR) - Defense World
Major Stock Purchases Signal Strong Confidence in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock By Investing.com - Investing.com UK
Petri Dish: VC firm's new $340M seed fund; Watertown biotech raises $185M - The Business Journals
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $80.50 - Defense World
Tectonic announces ~$185M capital raise - MSN
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Given New $112.00 Price Target at Wells Fargo & Company - MarketBeat
TECX (Tectonic Therapeutic Inc) may reap gains as insiders became active recently - Knox Daily
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Up 6.7% Following Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Tectonic secures $185 million in private equity funding - MSN
Tectonic Therapeutic to Raise $185 Million Via Private Investment in Public Equity Financing - Marketscreener.com
Tectonic Therapeutic Secures $185 Million in PIPE Deal - TipRanks
Tectonic Therapeutic announces $185M private placement - TipRanks
Tectonic Announces $185 Million Private Placement - The Manila Times
Tectonic secures $185 million in private equity funding By Investing.com - Investing.com UK
Tectonic Therapeutic, Inc. Announces $185 Million Private Investment in Public Equity Financing - Nasdaq
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Major Funding Alert: Tectonic Therapeutic Lands $185M from Elite Investors at Premium Price - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00 - Defense World
Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45 - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 13.3%Should You Sell? - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 13.3%Here's What Happened - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 6.7% on Analyst Upgrade - Defense World
Wall Street Rally: Dow Hits One-Month High as IBM Surges, Microsoft Declines – Market - HPBL
Tectonic’s Plates Shift On Positive Phase Ib PH-HFpEF Data - News & Insights
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):